Increased Cardiac Events With Sibutramine

Links shared publicly online about this topic

Air pollution is associated with increased cardiac events

news-medical.net — “Even healthy people exposed to ultrafine particulate pollution associated with traffic and fossil-fuel combustion for just two hours show changes in heart rhythm and evidence of clot formation that may herald the potential for serious cardiac events, according to research from the Environmental Protection Agency.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 23, 2010 at 8:12 am By:

NewsMedical News-Medical.Net Health News

Air pollution is associated with increased cardiac events: Even healthy people exposed to ultrafine particulate po... http://bit.ly/6XfF2z

2 years ago...

No Association Between Stimulant Treatment For ADHD And Increased Risk Of Cardiac Events In Youth

medicalnewstoday.com — “Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 10, 2012 at 9:05 am By:

mnt_cardiovasc MNT Cardiovascular Health News

No Association Between Stimulant Treatment For ADHD And Increased Risk Of Cardiac Events In Youth http://t.co/xVLu8w1q #cardiovascular

3 months ago...

Cancer drugs linked with cardiac and cerebrovascular events

theheart.org — “The cancer drugs sunitinib and sorafenib are associated with a significantly increased risk for arterial thromboembolic events.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on April 6, 2010 at 8:39 pm By:

theheartorg Shelley Wood Cardiology

Arterial thromboembolic events with sunitinib, sorafenib: The cancer drugs sunitinib and sorafenib are assoc... http://bit.ly/c4NX8s #ACC10

2 years ago...

Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review

fda.gov — “FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on November 21, 2009 at 11:02 pm By:

RitaRubin RitaRubin Health Communicator

FDA issues Sat. night safety alert: Prelimnary data link weight-loss drug Meridia to higher risk of cardiovascular events http://tr.im/Fsxr

3 years ago...

Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth

eurekalert.org — “Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on February 8, 2012 at 10:07 pm By:

adhdfever ADHD Fever Patient Expert

Stimulant treatment for ADHD not associated with increased risk of cardiac ... http://t.co/QSepAlBe

4 months ago...

Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth

psypost.org — “Stimulant treatment for ADHD not associated with increased risk of cardiac events in youthView full resource at psypost.org

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 4:40 am By:

adhdfever ADHD Fever Patient Expert

Stimulant treatment for ADHD not associated with increased risk of ... http://t.co/FJsJU1OX

4 months ago...

Studies Show No Increased Risk Of Cardiac Events In Diabetes Patients Treated With AFREZZA(R)

medicalnewstoday.com — “The findings of two separate studies further substantiate that treatment with the investigational ultra rapid acting mealtime insulin AFREZZA® (insulin human [rDNA origin]) Inhalation Powder dView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 28, 2011 at 7:05 am By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Studies Show No Increased Risk Of Cardiac Events In Diabetes Patients: http://bit.ly/l5GtT5 Full http://bit.ly/iiRD4r

11 months ago...

Sibutramine Increases Risk for MI and Stroke Among Patients with Heart Disease - Physician's First Watch

firstwatch.jwatch.org — “The weight-loss drug sibutramine (Meridia) -- up for review by FDA advisers on Sept. 15 -- poses increased risk for cardiovascular events among adults with cardiovascular disease (CVD), according to a New England Journal of . . . LINK(S):View full resource at firstwatch.jwatch.org

  • View Related
  • Share

Most Recently Shared on September 3, 2010 at 11:50 am By:

HeartDisease_OW Heart Disease OW OW Health

Sibutramine Increases Risk for MI and Stroke Among Patients with Heart Disease: (Source: Physician's First Watch c... http://bit.ly/dsc9Z7

2 years ago...

Sudden Cardiac Arrest

americanheart.org — “Sudden cardiac arrest is the abrupt loss of heart function in a person who may or may not have diagnosed heart disease. The time and mode of death are unexpected.View full resource at americanheart.org

  • View Related
  • Share

Most Recently Shared on October 5, 2009 at 2:53 pm By:

Smoking cessation increases cardiac health later in life

news-medical.net — “Smoking affects your cardiac health both before and after a major event like a heart attack. But how much? And does cutting back instead of quitting have a positive effect as well?View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 2, 2010 at 11:42 am By:

Obesity_News News-Medical.Net Health News

Obesity News: Smoking cessation increases cardiac health later in life: Smoking affects your cardiac health both... http://twurl.nl/nhig82

2 years ago...

Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride)

fda.gov — “FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo (sugar pill).View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on November 20, 2009 at 10:59 pm By:

nursingpins Vernon Dutton, R.N. Nurse

Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride) (FDA) http://tinyurl.com/yao2rsg

3 years ago...

Abbott Withdraws Sibutramine From Market - QualityPoint Technologies

qualitypointtech.net — “The US FDA asked the manufacturer to pull the weight-loss medication from the market after clinical trial data pointed to a 16% increase in the risk for serious cardiovascular events. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 8, 2010 at 7:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Abbott Withdraws Sibutramine From Market: The US FDA asked the manufacturer to pull the weight-loss medication fro... http://bit.ly/dnW9TT

2 years ago...

FDA Alert: Meridia (sibutramine): Market Withdrawal Due to Risk of Serious Cardiovascular Events

drugs.com — “FDA Alert: Meridia (sibutramine): Market Withdrawal Due to Risk of Serious Cardiovascular EventsView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 8, 2010 at 8:26 pm By:

drugscom Drugs.com Health Site

FDA Alert - Market Withdrawal of Meridia (sibutramine) - Risk of Serious Cardiovascular Events - http://bit.ly/bEJE4K

2 years ago...

Symposier - Cardiovascular Risk with Meridia - sibutramine (FDA April 2010)

symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru FDA is alerting healthcare professionals that Meridia (sibutramine) is contraindicated in patients with a history of cardiovascular disease because the drug increases their risk of heart attack and stroke. Meridia is used to manage obesity. In November 2009, an early communication from FDA reported preliminary study results suggesting that patients on Meridia had a greater frequency of cardiovascular events than those not taking the drug. AdditionalView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 12:58 am By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

Cardiovascular Risk with Meridia - Sibutramine (FDA April 2010). http://bit.ly/c52FJo

2 years ago...

Cardiac Rehab Patients Do Not Gain From Increased Amount Of Resistance Training

medicalnewstoday.com — “Aerobic exercise training (AT) is generally advised for individuals undergoing rehabilitation after cardiac events. Due to enhancing muscular strength and endurance, functional capacity and indepeView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 2:45 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Cardiac Rehab Patients Do Not Gain From Increased Amount Of Resistance: http://t.co/ew3bcfM Full http://t.co/mn6oXG9

9 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390